There are many important global implications of UDI that I will highlight during my presentation.
SANTA BARBARA, CALIFORNIA (PRWEB) November 04, 2014
USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of Unique Device Identification Services and Solutions, will discuss global UDI regulations at GS1 Germany Healthcare Live.
GS1 Germany Healthcare Live is an opportunity for hospital, medical device and pharmaceutical representatives to come together to discuss standards to make the healthcare supply chain safer and more efficient. Crowley will discuss Unique Device Identification (UDI) implementation, adoption and use.
“I look forward to continuing to work with European manufacturers on the implementation and harmonization of UDI,” said Crowley. “There are many important global implications of UDI that I will highlight during my presentation.”
Global UDI Compliance - Challenges and Opportunities of Device Identification
Thursday, November 6, 2014 at 14:00 (local time)
- The evolving state of US UDI implementation
- Implications for global adoption and implementation
- Potential differences between the US and other countries
- Issues and challenges with current implementation
GS1 Germany Healthcare Live is November 5-6, 2014 at the Maritim Hotel in Bonn, Germany.
As Vice President of UDI Services and Solutions at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage with UDI implementation.
Crowley held various positions over nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA’s Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA’s Unique Device Identification System.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit http://www.usdm.com.